Methylene blue is associated with poor outcomes in vasoplegic shock.
Methylene blue is associated with poor outcomes in vasoplegic shock.
M. Weiner,Hung-mo Lin,3 Authors,G. Fischer
2013 · DOI: 10.1053/j.jvca.2013.02.026
Journal of Cardiothoracic and Vascular Anesthesia · 62 Citations
TLDR
The use of methylene blue as treatment for vasoplegia to be independently associated with poor outcomes is identified and, perhaps, it should be relegated to rescue use and not as first-line therapy.